Charlottesville, VA, United States of America

Galina V Yamshchikov

This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Galina V Yamshchikov. Retrieved from https://idiyas.com/inventor/galina-v-yamshchikov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Galina V Yamshchikov: Innovator in Retrovirus Research

Introduction

Galina V Yamshchikov is a prominent inventor based in Charlottesville, VA (US). She has made significant contributions to the field of virology, particularly in the development of retrovirus-like particles. Her work has implications for immunogenic compositions and methods for protecting against retrovirus infections.

Latest Patents

Galina holds a patent for "Virus-like particles, methods and immunogenic compositions." This patent provides retrovirus-like particles that comprise retrovirus env proteins. It also details immunogenic compositions that include these particles, methods for their production, and approaches for protecting animals or humans from retrovirus infections using the particles.

Career Highlights

Galina is affiliated with Emory University, where she continues her research and innovation in virology. Her work has been instrumental in advancing our understanding of retroviral mechanisms and potential therapeutic strategies.

Collaborations

One of her notable collaborators is Richard W Compans, with whom she has worked on various research projects related to retrovirus-like particles.

Conclusion

Galina V Yamshchikov's contributions to retrovirus research highlight her role as an innovator in the field. Her patent and ongoing work at Emory University continue to pave the way for advancements in virology and immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…